It's something like 27 more gallbladder-related events per every 10,000 patients treated per year, so it's a pretty small absolute risk. He added that the incidence of gallbladder events often increases after weight loss in general, but some studies suggest that GLP-1 drugs slow down gallbladder motility which could create a sludge that leads to gallstones (8)
These might include: Pregnancy test : Essential first step for any woman of reproductive age with menstrual changes Blood tests : To assess hormone levels (FSH, LH, oestradiol, prolactin, thyroid function) and full blood count if bleeding is heavy STI screening : Particularly for unexplained intermenstrual or postcoital bleeding Pelvic ultrasound : If structural causes need to be excluded Review of medication : To ensure no drug interactions or other contributing factors Keep a menstrual diary noting cycle length, flow heaviness, and any associated symptoms
In Type 2 diabetes, GLP-1 agonists help manage blood sugar by triggering the pancreas to release more insulin
Quick tip: When reading trial results, separate average weight change from personal expectations
Receptor Activity Activation of GLP-1, GIP, and glucagon receptors by retatrutide plays different roles in the body